Results 161 to 170 of about 13,154 (208)

Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes. [PDF]

Medicine (Baltimore)
Şahin MF, Erol A, Bayrak G, Şahin A.
europepmc   +1 more source

Identifying optimal primary prevention interventions for major cardiovascular disease events and all-cause mortality: a systematic review and hierarchical network meta-analysis of RCTs.

Health Technol Assess
Uthman OA, Court R, Enderby J, Nduka C, Al-Khudairy L, Anjorin S, Mistry H, Melendez-Torres GJ, Taylor-Phillips S, Clarke A.   +9 more
europepmc   +1 more source

Mendelian randomization analysis of lipid-lowering drug targets and neuropsychiatric disorders. [PDF]

Medicine (Baltimore)
Peng S, Liu M, Du F, Li K.
europepmc   +1 more source

HMG-CoA reductase inhibition preserves testicular function after torsion/detorsion by modulating oxidative stress and AKT signaling. [PDF]

Sci Rep
Yıldırım B, Baygül O, Şengün N, Üstündağ ÜV, Ateş N, Balçıkanlı Z, Beker MÇ, Keskin İ, Kılıç E.   +8 more
europepmc   +1 more source

Activity-based probes and chemical proteomics uncover the biological impact of targeting HMG-CoA Synthase 1 in the mevalonate pathway. [PDF]

J Biol Chem
Yi SA, Sun L, Rao Y, Ordureau A, Lewis JS, An H.   +5 more
europepmc   +1 more source

Medulloblastoma response to mevalonate pathway inhibition is independent of p53 status. [PDF]

Biol Direct
Comer C, Edwards C, Caporali S, Lu Y, Butera A, Michod D, Gruber AJ, Amelio I, Niklison-Chirou MV.   +8 more
europepmc   +1 more source

Are lipid-lowering drugs harmful to cognitive performance?: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Han L, Su C, Lian R, Han J, Fan X, Gao L.   +5 more
europepmc   +1 more source

Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events. [PDF]

Ann Med
Vuorio A, Kovanen PT, Strandberg T.
europepmc   +1 more source

Cryo-EM structures of apo and atorvastatin-bound human 3-hydroxy-3-methylglutaryl-coenzyme A reductase. [PDF]

Acta Crystallogr F Struct Biol Commun
Karuppasamy M, van Rooyen J.
europepmc   +1 more source

Exploring the Association Between Lipid-Lowering Medications and Dry Eye Disease in COVID-19 Patients. [PDF]

Rom J Ophthalmol
Gushansky KY, Sutinen P, Jeon S, Tuuminen R.   +3 more
europepmc   +1 more source